title: Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen.
authors.forename: M E
authors.initials: ME
authors.lastname: O'Brien
authors.forename: S
authors.initials: S
authors.lastname: Casey
authors.forename: J
authors.initials: J
authors.lastname: Treleaven
authors.forename: T J
authors.initials: TJ
authors.lastname: Powles
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000628:therapy*; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin / Q000009:adverse effects; D013629:Tamoxifen / Q000009:adverse effects
chemical_list: D013629:Tamoxifen; D004921:Erythropoietin; D016685:Mitomycin